XML 228 R3.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Profit and Loss - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Continuing Operations      
Net revenue € 5,098,691 € 4,486,724 € 4,318,073
Cost of sales (2,757,459) (2,437,164) (2,166,062)
Gross Margin 2,341,232 2,049,560 2,152,011
Research and Development (276,018) (240,661) (288,320)
Selling, General and Administration expenses (942,821) (814,775) (860,348)
Operating Expenses (1,218,839) (1,055,436) (1,148,668)
Profit/(loss) of equity accounted investees with similar activity to that of the Group 8,972    
Operating Result 1,131,365 994,124 1,003,343
Finance income 114,197 13,995 9,678
Finance costs (342,965) (293,273) (263,344)
Change in fair value of financial instruments 1,326   (3,752)
Impairment of financial assets at amortized cost (37,666) 30,280 (18,844)
Exchange differences (9,616) (8,246) (11,472)
Finance result (274,724) (257,244) (287,734)
Share of losses of equity accounted investees (39,538) (11,038) (19,887)
Profit before income tax from continuing operations 817,103 725,842 695,722
Income tax expense (168,459) (131,436) (34,408)
Profit after income tax from continuing operations 648,644 594,406 661,314
Consolidated profit for the year 648,644 594,406 661,314
Profit attributable to the Parent 625,146 596,642 662,700
Loss attributable to non-controlling interest € 23,498 € (2,236) € (1,386)
Basic earnings per share (Euros) € 0.91 € 0.87 € 0.97
Diluted earnings per share (Euros) € 0.91 € 0.87 € 0.97